{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:15:12Z","timestamp":1783379712618,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["7222243"],"award-info":[{"award-number":["7222243"]}]},{"DOI":"10.13039\/100016692","name":"Key R&D Program of Ningxia Hui Autonomous Region","doi-asserted-by":"crossref","award":["2025BEG01011"],"award-info":[{"award-number":["2025BEG01011"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Planning Project of Tibet Autonomous Region","award":["XZ202501JD0021"],"award-info":[{"award-number":["XZ202501JD0021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16138-4","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:16:24Z","timestamp":1778642184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid-dominated metabolites mediate the association between low body mass index and esophageal malignancy: a population-based nested case-control study"],"prefix":"10.1186","volume":"26","author":[{"given":"Mengfei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"16138_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"16138_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/gutjnl-2017-315520","volume":"68","author":"Z He","year":"2019","unstructured":"He Z, Liu Z, Liu M, Guo C, Xu R, Li F, et al. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial. Gut. 2019;68:198\u2013206. https:\/\/doi.org\/10.1136\/gutjnl-2017-315520.","journal-title":"Gut"},{"key":"16138_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ijc.20616","volume":"113","author":"GD Tran","year":"2005","unstructured":"Tran GD, Sun X, Abnet CC, Fan J, Dawsey SM, Dong Z, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005;113:456\u201363.","journal-title":"Int J Cancer"},{"key":"16138_CR4","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.cgh.2017.03.019","volume":"15","author":"M Liu","year":"2017","unstructured":"Liu M, Liu Z, Cai H, Guo C, Li X, Zhang C, et al. A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China. Clin Gastroenterol Hepatol. 2017;15:1538\u2013e467. https:\/\/doi.org\/10.1016\/j.cgh.2017.03.019.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"16138_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ijc.33208","volume":"148","author":"W Chen","year":"2021","unstructured":"Chen W, Li H, Ren J, Zheng R, Shi J, Li J, et al. Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China. Int J Cancer. 2021;148:329\u201339. https:\/\/doi.org\/10.1002\/ijc.33208.","journal-title":"Int J Cancer"},{"key":"16138_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/carcin\/bgt480","volume":"35","author":"TN Seyfried","year":"2014","unstructured":"Seyfried TN, Flores RE, Poff AM, D\u2019Agostino DP. Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis. 2014;35:515\u201327. https:\/\/doi.org\/10.1093\/carcin\/bgt480.","journal-title":"Carcinogenesis"},{"key":"16138_CR7","doi-asserted-by":"publisher","first-page":"109965","DOI":"10.1016\/j.isci.2024.109965","volume":"27","author":"M Liu","year":"2024","unstructured":"Liu M, Tian H, Wang M, Guo C, Xu R, Li F, et al. Construction and validation of serum Metabolic Risk Score for early warning of malignancy in esophagus. iScience. 2024;27:109965. https:\/\/doi.org\/10.1016\/j.isci.2024.109965.","journal-title":"iScience"},{"key":"16138_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41416-021-01395-w","volume":"125","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Zhao Z, Xue L, Wang G, Song H, Pang R, et al. Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning. Br J Cancer. 2021;125:351\u20137. https:\/\/doi.org\/10.1038\/s41416-021-01395-w.","journal-title":"Br J Cancer"},{"key":"16138_CR9","doi-asserted-by":"publisher","first-page":"790933","DOI":"10.3389\/fonc.2022.790933","volume":"12","author":"PP Wang","year":"2022","unstructured":"Wang PP, Song X, Zhao XK, Wei MX, Gao SG, Zhou FY, et al. Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma. Front Oncol. 2022;12:790933. https:\/\/doi.org\/10.3389\/fonc.2022.790933.","journal-title":"Front Oncol"},{"key":"16138_CR10","doi-asserted-by":"publisher","first-page":"340038","DOI":"10.1016\/j.aca.2022.340038","volume":"1220","author":"J Zhao","year":"2022","unstructured":"Zhao J, Zhao X, Yu J, Gao S, Zhang M, Yang T, et al. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma. Anal Chim Acta. 2022;1220:340038. https:\/\/doi.org\/10.1016\/j.aca.2022.340038.","journal-title":"Anal Chim Acta"},{"key":"16138_CR11","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1210\/jc.2017-02114","volume":"103","author":"F Ottosson","year":"2018","unstructured":"Ottosson F, Brunkwall L, Ericson U, Nilsson PM, Almgren P, Fernandez C, et al. Connection Between BMI-Related Plasma Metabolite Profile and Gut Microbiota. J Clin Endocrinol Metab. 2018;103:1491\u2013501. https:\/\/doi.org\/10.1210\/jc.2017-02114.","journal-title":"J Clin Endocrinol Metab"},{"key":"16138_CR12","doi-asserted-by":"publisher","first-page":"e0148361","DOI":"10.1371\/journal.pone.0148361","volume":"11","author":"JE Ho","year":"2016","unstructured":"Ho JE, Larson MG, Ghorbani A, Cheng S, Chen MH, Keyes M, et al. Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes. PLoS ONE. 2016;11:e0148361. https:\/\/doi.org\/10.1371\/journal.pone.0148361.","journal-title":"PLoS ONE"},{"key":"16138_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11306-013-0574-1","volume":"10","author":"SC Moore","year":"2014","unstructured":"Moore SC, Matthews CE, Sampson JN, Stolzenberg-Solomon RZ, Zheng W, Cai Q, et al. Human metabolic correlates of body mass index. Metabolomics: Official J Metabolomic Soc. 2014;10:259\u201369. https:\/\/doi.org\/10.1007\/s11306-013-0574-1.","journal-title":"Metabolomics: Official J Metabolomic Soc"},{"key":"16138_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/jnci\/djx244","volume":"110","author":"SC Moore","year":"2018","unstructured":"Moore SC, Playdon MC, Sampson JN, Hoover RN, Trabert B, Matthews CE, et al. A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk. J Natl Cancer Inst. 2018;110:588\u201397. https:\/\/doi.org\/10.1093\/jnci\/djx244.","journal-title":"J Natl Cancer Inst"},{"key":"16138_CR15","doi-asserted-by":"publisher","unstructured":"Yang M, Zhu C, Du L, Huang J, Lu J, Yang J, et al. A Metabolomic Signature of Obesity and Risk of Colorectal Cancer: Two Nested Case-Control Studies. Metabolites. 2023;13. https:\/\/doi.org\/10.3390\/metabo13020234.","DOI":"10.3390\/metabo13020234"},{"key":"16138_CR16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/jgh.14917","volume":"35","author":"J Tian","year":"2020","unstructured":"Tian J, Zuo C, Liu G, Che P, Li G, Li X, et al. Cumulative evidence for the relationship between body mass index and the risk of esophageal cancer: An updated meta-analysis with evidence from 25 observational studies. J Gastroenterol Hepatol. 2020;35:730\u201343. https:\/\/doi.org\/10.1111\/jgh.14917.","journal-title":"J Gastroenterol Hepatol"},{"key":"16138_CR17","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1002\/cam4.2444","volume":"8","author":"X Yang","year":"2019","unstructured":"Yang X, Zhang T, Yin X, Yuan Z, Chen H, Plymoth A, et al. Adult height, body mass index change, and body shape change in relation to esophageal squamous cell carcinoma risk: A population-based case-control study in China. Cancer Med. 2019;8:5769\u201378. https:\/\/doi.org\/10.1002\/cam4.2444.","journal-title":"Cancer Med"},{"key":"16138_CR18","doi-asserted-by":"publisher","unstructured":"Liu M, Yang W, Guo C, Liu Z, Li F, Liu A, et al. Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial. J Clin Oncol. 2024;Jco2301284. https:\/\/doi.org\/10.1200\/jco.23.01284.","DOI":"10.1200\/jco.23.01284"},{"key":"16138_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jclinepi.2019.06.009","volume":"114","author":"C Shi","year":"2019","unstructured":"Shi C, Liu M, Liu Z, Guo C, Li F, Xu R, et al. Using health insurance reimbursement data to identify incident cancer cases. J Clin Epidemiol. 2019;114:141\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2019.06.009.","journal-title":"J Clin Epidemiol"},{"key":"16138_CR20","doi-asserted-by":"publisher","first-page":"100312","DOI":"10.1016\/j.eclinm.2020.100312","volume":"20","author":"H Tian","year":"2020","unstructured":"Tian H, Yang W, Hu Y, Liu Z, Chen L, Lei L, et al. Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China. EClinicalMedicine. 2020;20:100312. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100312.","journal-title":"EClinicalMedicine"},{"key":"16138_CR21","doi-asserted-by":"publisher","first-page":"101394","DOI":"10.1016\/j.eclinm.2022.101394","volume":"47","author":"M Liu","year":"2022","unstructured":"Liu M, Zhou R, Liu Z, Guo C, Xu R, Zhou F, et al. Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general population. EClinicalMedicine. 2022;47:101394. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101394.","journal-title":"EClinicalMedicine"},{"key":"16138_CR22","doi-asserted-by":"publisher","first-page":"e0132613","DOI":"10.1371\/journal.pone.0132613","volume":"10","author":"BW Eom","year":"2015","unstructured":"Eom BW, Joo J, Kim S, Shin A, Yang HR, Park J, et al. Prediction Model for Gastric Cancer Incidence in Korean Population. PLoS ONE. 2015;10:e0132613. https:\/\/doi.org\/10.1371\/journal.pone.0132613.","journal-title":"PLoS ONE"},{"key":"16138_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.21147\/j.issn.1000-9604.2020.05.05","volume":"32","author":"M Cao","year":"2020","unstructured":"Cao M, Li H, Sun D, Lei L, Ren J, Shi J, et al. Classifying risk level of gastric cancer: Evaluation of questionnaire-based prediction model. Chin J Cancer Res. 2020;32:605\u201313. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2020.05.05.","journal-title":"Chin J Cancer Res"},{"key":"16138_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.21147\/j.issn.1000-9604.2021.06.02","volume":"33","author":"R Zhou","year":"2021","unstructured":"Zhou R, Zheng H, Liu M, Liu Z, Guo C, Tian H, et al. Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations. Chin J Cancer Res. 2021;33:649\u201358. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2021.06.02.","journal-title":"Chin J Cancer Res"},{"key":"16138_CR25","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1097\/cm9.0000000000002903","volume":"137","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu Z, Chen Y, Ji P, Fang Z, He Y, et al. Development and external validation of a quantitative diagnostic model for malignant gastric lesions in clinical opportunistic screening: A multicenter real-world study. Chin Med J (Engl). 2024;137:2343\u201350. https:\/\/doi.org\/10.1097\/cm9.0000000000002903.","journal-title":"Chin Med J (Engl)"},{"key":"16138_CR26","first-page":"819","volume":"11","author":"Z Yang","year":"2019","unstructured":"Yang Z, Liu Y, Ma L, Wen X, Ji H, Li K. Exploring potential biomarkers of early stage esophageal squamous cell carcinoma in pre- and post-operative serum metabolomic fingerprint spectrum using (1)H-NMR method. Am J translational Res. 2019;11:819\u201331.","journal-title":"Am J translational Res"},{"key":"16138_CR27","doi-asserted-by":"publisher","first-page":"829350","DOI":"10.3389\/fonc.2022.829350","volume":"12","author":"M Yu","year":"2022","unstructured":"Yu M, Wen W, Yi X, Zhu W, Aa J, Wang G. Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma. Front Oncol. 2022;12:829350. https:\/\/doi.org\/10.3389\/fonc.2022.829350.","journal-title":"Front Oncol"},{"key":"16138_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/oby.23619","volume":"31","author":"JF Dorgan","year":"2023","unstructured":"Dorgan JF, Ryan AS, LeBlanc ES, Van Horn L, Magder LS, Snetselaar LG, et al. A comparison of associations of body mass index and dual-energy x-ray absorptiometry measured percentage fat and total fat with global serum metabolites in young women. Obes (Silver Spring Md). 2023;31:525\u201336. https:\/\/doi.org\/10.1002\/oby.23619.","journal-title":"Obes (Silver Spring Md)"},{"key":"16138_CR29","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/ijo.2017.124","volume":"41","author":"N Geidenstam","year":"2017","unstructured":"Geidenstam N, Al-Majdoub M, Ekman M, Sp\u00e9gel P, Ridderstr\u00e5le M. Metabolite profiling of obese individuals before and after a one year weight loss program. Int J Obes (Lond). 2017;41:1369\u201378. https:\/\/doi.org\/10.1038\/ijo.2017.124.","journal-title":"Int J Obes (Lond)"},{"key":"16138_CR30","doi-asserted-by":"publisher","first-page":"101342","DOI":"10.1016\/j.molmet.2021.101342","volume":"54","author":"SK Das","year":"2021","unstructured":"Das SK, Ainsworth HC, Dimitrov L, Okut H, Comeau ME, Sharma N, et al. Metabolomic architecture of obesity implicates metabolonic lactone sulfate in cardiometabolic disease. Mol Metabolism. 2021;54:101342. https:\/\/doi.org\/10.1016\/j.molmet.2021.101342.","journal-title":"Mol Metabolism"},{"key":"16138_CR31","doi-asserted-by":"publisher","unstructured":"Zhu X, Wang K, Liu G, Wang Y, Xu J, Liu L, et al. Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer. Gastroenterol Res Pract. 2017;2017(5469597). https:\/\/doi.org\/10.1155\/2017\/5469597.","DOI":"10.1155\/2017\/5469597"},{"key":"16138_CR32","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.clnu.2023.05.011","volume":"42","author":"M N\u00e4\u00e4t\u00e4nen","year":"2023","unstructured":"N\u00e4\u00e4t\u00e4nen M, K\u00e5rlund A, Mikkonen S, Kl\u00e5vus A, Savolainen O, Lehtonen M, et al. Metabolic profiles reflect weight loss maintenance and the composition of diet after very-low-energy diet. Clin Nutr. 2023;42:1126\u201341. https:\/\/doi.org\/10.1016\/j.clnu.2023.05.011.","journal-title":"Clin Nutr"},{"key":"16138_CR33","doi-asserted-by":"publisher","unstructured":"Perng W, Rahman ML, Aris IM, Michelotti G, Sordillo JE, Chavarro JE, et al. Metabolite Profiles of the Relationship between Body Mass Index (BMI) Milestones and Metabolic Risk during Early Adolescence. Metabolites. 2020;10. https:\/\/doi.org\/10.3390\/metabo10080316.","DOI":"10.3390\/metabo10080316"},{"key":"16138_CR34","doi-asserted-by":"publisher","first-page":"721990","DOI":"10.3389\/fmolb.2021.721990","volume":"8","author":"B Zang","year":"2021","unstructured":"Zang B, Wang W, Wang Y, Li P, Xia T, Liu X, et al. Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma. Front Mol Biosci. 2021;8:721990. https:\/\/doi.org\/10.3389\/fmolb.2021.721990.","journal-title":"Front Mol Biosci"},{"key":"16138_CR35","doi-asserted-by":"publisher","unstructured":"Li C, Wang Q, Ma J, Shi S, Chen X, Yang H, et al. Integrative Pathway Analysis of Genes and Metabolites Reveals Metabolism Abnormal Subpathway Regions and Modules in Esophageal Squamous Cell Carcinoma. Molecules. 2017;22. https:\/\/doi.org\/10.3390\/molecules22101599.","DOI":"10.3390\/molecules22101599"},{"key":"16138_CR36","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1158\/1055-9965.Epi-20-1633","volume":"30","author":"X Shu","year":"2021","unstructured":"Shu X, Cai H, Lan Q, Cai Q, Ji BT, Zheng W, et al. A Prospective Investigation of Circulating Metabolome Identifies Potential Biomarkers for Gastric Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2021;30:1634\u201342. https:\/\/doi.org\/10.1158\/1055-9965.Epi-20-1633.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"16138_CR37","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1021\/acs.jproteome.6b00936","volume":"16","author":"P Kamarajan","year":"2017","unstructured":"Kamarajan P, Rajendiran TM, Kinchen J, Berm\u00fadez M, Danciu T, Kapila YL. Head and Neck Squamous Cell Carcinoma Metabolism Draws on Glutaminolysis, and Stemness Is Specifically Regulated by Glutaminolysis via Aldehyde Dehydrogenase. J Proteome Res. 2017;16:1315\u201326. https:\/\/doi.org\/10.1021\/acs.jproteome.6b00936.","journal-title":"J Proteome Res"},{"key":"16138_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016;23:27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006.","journal-title":"Cell Metab"},{"key":"16138_CR39","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.18632\/oncotarget.1561","volume":"5","author":"Y Togashi","year":"2014","unstructured":"Togashi Y, Arao T, Kato H, Matsumoto K, Terashima M, Hayashi H, et al. Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production. Oncotarget. 2014;5:2962\u201373. https:\/\/doi.org\/10.18632\/oncotarget.1561.","journal-title":"Oncotarget"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16138-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16138-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16138-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:42:28Z","timestamp":1783377748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16138-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16138"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16138-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Peking University School of Oncology, China (Approval number: 2011101110), and performed in accordance with the Declaration of Helsinki. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"819"}}